Access cutting-edge nasopharyngeal cancer treatment through this clinical trial at a research site in Boise. Study-provided care at no cost to qualified participants.
Access nasopharyngeal cancer specialists in Boise at no cost
This study follows strict safety protocols and ethical guidelines
All study-related nasopharyngeal cancer treatment provided free
This phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib works in treating patients with nasopharyngeal cancer that has come back (after a period of improvement) (recurrent), has spread from where it first started (primary site) to other places in the body (metastatic), or for which no treatment is currently available (incurable). Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this nasopharyngeal cancer clinical trial in Boise, ID
If you're searching for nasopharyngeal cancer treatment options in Boise, ID, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boise research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nasopharyngeal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.